OPY Acquisition I, a blank check company formed by Oppenheimer targeting healthcare, raised $110 million by offering 11 million units at $10 per unit. The company offered 1 million more units than anticipated. Each unit consists of share of common stock and one-half of a warrant, exercisable at $11.50
OPY Acquisition I is led by CEO and Chairman Jonathan Siegel, founder and CEO of JBS Healthcare Ventures, and CFO Daniel Geffken, co-founder and Managing Director of Danforth Advisors. The company plans to leverage management's life science experience to target healthcare companies with a primary focus on novel therapeutics, medical devices, or healthcare services.
OPY Acquisition I plans to list on the Nasdaq under the symbol OHAAU. Oppenheimer & Co., and Lake Street Capital Markets acted as lead managers on the deal.
